* Vyant Bio Inc VYNT.OQ VYNT.O is expected to report
results on August 22.
* The Cherry Hill New Jersey-based company is expected to
report
revenue of $200 thousand, according to the estimate from one
analyst, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Vyant Bio Inc is
for a
loss of 15 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Vyant Bio
Inc is
$3, above its last closing price of $0.79.
This summary was machine generated August 19 at 20:39 GMT. All
figures in US dollars unless otherwise stated